Wegovy® tablets and burping

A normal reflex that can become a nuisance

Burping releases air from the stomach. Every swallow of food or drink takes some air with it; when air collects in the upper stomach it stretches the stomach wall, the muscle at the bottom of the food pipe relaxes, and the air escapes through the mouth ^[6]. NIH describes belching up to 30 times a day as typical, and notes that some people burp a lot because they swallow air and let it out before it even reaches the stomach ^[7].

The Wegovy® documents list it plainly: “belching” among the US Medication Guide’s most common side effects and “burping” among the EU tablet leaflet’s common ones ^[1][2]. Trial tables call it eructation.

Registry counts for oral semaglutide

Unlike bloating, burping crossed the registry’s 5% reporting line in the 25 mg trial, so a tablet figure exists. Here it is beside the other numbers people often quote.

Why 10.3% and “common” can both be right

The EU leaflet places burping in its “common” group (up to 1 in 10 people), while the registry shows slightly more than 1 in 10. The two are measuring different things. The EU table classifies adverse reactions, and for most of them it takes the frequency from the injection trials, stating that OASIS 4 frequencies were similar except for indigestion ^[2]. The registry lists treatment-emergent adverse events, meaning anything that started during treatment, related to the medicine or not, and the sponsor entered it without peer review ^[3].

Sample size matters as well. In the tablet arm each person moves the percentage by about half a point, and in the placebo arm by about one point, so small shifts in the counts change the figures noticeably. The gap from placebo is clear; its exact size is not.

For context outside the weight programme, Rybelsus®, which contains the same molecule for type 2 diabetes at lower doses, reports burping in 2% on 14 mg and 0.6% on 7 mg against none on placebo ^[5]. It is a different product used by different people, so its numbers do not carry over.

Timing: mostly while the dose is climbing

The EU table marks burping as seen mainly in the dose-escalation period ^[2]. In the US, the tablet starts at 1.5 mg and moves through 4 mg and 9 mg to 25 mg in 30-day steps, a schedule the label describes as lowering the risk of digestive reactions, and a prescriber may delay a step that is not tolerated ^[1]. The trial itself climbed through slightly different strengths, 3, 7 and 14 mg, before reaching 25 mg at week 13 ^[3]; the Rybelsus® label reports that those strengths and the marketed 1.5, 4 and 9 mg tablets showed no clinically significant difference in steady-state exposure in healthy volunteers ^[5].

No document reports how long burping lasted or whether it eased at 25 mg. If it keeps going or bothers you, the Medication Guide asks you to raise it ^[1].

What may produce the extra burps

• What the label supports: semaglutide slows stomach emptying ^[1], so food and swallowed air may stay longer in the upper stomach, where MedlinePlus says stretching sets off a belch ^[6]. The chain is reasonable but has not been measured for burping on the tablet.
• Linked symptoms: on the tablet, nausea (46.6%) and indigestion (18.1%) were far more common than on placebo ^[2], and MedlinePlus notes that burping can relieve nausea, indigestion and heartburn ^[6]. NIH lists belching among the symptoms of indigestion ^[12]. Some people may burp more because their stomach already feels unsettled.
• Reflux: GERD was recorded in 7.8% on the tablet versus 4.9% on placebo ^[3], and MedlinePlus names reflux disease as a cause of abnormal belching ^[6].
• Behaviour: specialists separate gastric belching, the normal venting of stomach air, from supragastric belching, where air is drawn into the food pipe and pushed straight out again; a 2020 review describes excessive belching as often a learned response to an unpleasant feeling in the abdomen ^[9]. Whether this plays a part on the tablet has not been studied.

Burping that has other causes

Swallowing more air is the commonest everyday reason: chewing gum, sucking hard sweets, fizzy drinks, eating or drinking fast, smoking and loose-fitting dentures all add to it ^[7]. Conditions that can increase gas symptoms include functional dyspepsia, reflux disease, gastroparesis, coeliac disease and irritable bowel syndrome ^[7]. MedlinePlus adds digestive diseases in general and unconscious air swallowing, called aerophagia ^[6].

Steps described by NIH and MedlinePlus

NIH suggests swallowing less air: avoid gum, hard sweets, fizzy drinks and straws, do not talk while eating or drinking, eat slowly and sit down for meals, and have dentures checked if they are loose ^[8]. MedlinePlus adds avoiding gas-producing foods and drinks and eating quickly, and says lying on your side or in a knee-to-chest position can help trapped gas pass ^[6]. For chronic, troublesome belching, the review above names speech therapy and cognitive behavioural therapy as the main approaches used by specialists ^[9].

For the tablet routine itself, the label allows water only, up to 4 ounces, and the manufacturer’s page describes it as a sip of plain water; nothing else, fizzy drinks included, until 30 minutes have passed ^[1][11]. NIH says doctors may suggest over-the-counter medicines for gas symptoms depending on the cause, and the Medication Guide asks you to mention every such product to your provider ^[1][8].

Wegovy® and Rybelsus® are registered trademarks of Novo Nordisk A/S. PepLabo is not affiliated with or endorsed by Novo Nordisk.

When to get help